Oncologists, imaging groups and private payers are voicing strong support for CMS' Aug. 13 proposal to lift coverage-with-evidence-development requirements for the use of positron emission tomography in the initial, pre-treatment staging of cervical cancer. Writing for several imaging groups, the Academy of Molecular Imaging points out that the National Oncologic PET Registry has already collected enough data to demonstrate the usefulness of PET in helping physicians manage cervical cancer.The...